Healthcare
Tuesday, September 6, 2016
BRIEF-Walvax Biotechnology to divest stake in Shandong biotech unit
* Says it enters into an agreement to transfer 40 percent
stake and 45 percent stake in its Shandong-based biotechnology
unit to a Shenzhen investment management limited partnership(LP)
and a Yuxi investment management LP respectively
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment